Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 103,386 | 93,688 | 98,822 | 96,131 | 91,588 |
| Cost of Goods | 1,316 | 1,250 | 1,354 | 1,275 | 1,384 |
| Gross Profit | 102,070 | 92,438 | 97,468 | 94,856 | 90,204 |
| Operating Expenses | 70,954 | 65,919 | 61,158 | 58,899 | 58,645 |
| Operating Income | 31,432 | 26,769 | 36,664 | 36,232 | 31,943 |
| Other Income | 630 | 80 | 72 | 72 | 110 |
| Pre-tax Income | 32,062 | 26,849 | 36,736 | 36,304 | 32,053 |
| Income Tax | 4,650 | 4,052 | 16,349 | -5,833 | 5,530 |
| Net Income Continuous | 27,412 | 22,797 | 20,387 | 42,137 | 26,523 |
| Net Income | $27,412 | $22,797 | $20,387 | $42,137 | $26,523 |
| EPS Basic Total Ops | 0.26 | 0.22 | 0.28 | 0.26 | 0.23 |
| EPS Basic Continuous Ops | 0.26 | 0.22 | 0.18 | 0.36 | 0.23 |
| EPS Diluted Total Ops | 0.24 | 0.20 | 0.26 | 0.24 | 0.21 |
| EPS Diluted Continuous Ops | 0.24 | 0.20 | 0.17 | 0.34 | 0.21 |
| EBITDA(a) | $32,864 | $28,677 | $42,953 | $37,003 | $31,505 |